You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 17, 2024

CEQUA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cequa, and when can generic versions of Cequa launch?

Cequa is a drug marketed by Sun Pharm and is included in one NDA. There are four patents protecting this drug.

This drug has thirty-six patent family members in twenty-four countries.

The generic ingredient in CEQUA is cyclosporine. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cequa

A generic version of CEQUA was approved as cyclosporine by HIKMA on October 29th, 1999.

  Try a Trial

US Patents and Regulatory Information for CEQUA

CEQUA is protected by four US patents.

Patents protecting CEQUA


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Topical cyclosporine-containing formulations and uses thereof
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

Topical formulations and uses thereof
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm CEQUA cyclosporine SOLUTION;OPHTHALMIC 210913-001 Aug 14, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Sun Pharm CEQUA cyclosporine SOLUTION;OPHTHALMIC 210913-001 Aug 14, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Sun Pharm CEQUA cyclosporine SOLUTION;OPHTHALMIC 210913-001 Aug 14, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CEQUA

See the table below for patents covering CEQUA around the world.

Country Patent Number Title Estimated Expiration
Croatia P20230559 ⤷  Try a Trial
South Africa 201904704 TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF ⤷  Try a Trial
European Patent Office 3423076 FORMULATIONS À USAGE TOPIQUE CONTENANT DE LA CYCLOSPORINE ET LEURS UTILISATIONS (TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for CEQUA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2049079 LUC00006 Luxembourg ⤷  Try a Trial PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing